MwanzoLSTA • NASDAQ
add
Lisata Therapeutics Inc
Bei iliyotangulia
$ 2.82
Bei za siku
$ 2.86 - $ 2.94
Bei za mwaka
$ 2.05 - $ 3.83
Thamani ya kampuni katika soko
23.99M USD
Wastani wa hisa zilizouzwa
elfu 15.39
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
(USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato | — | — |
Matumizi ya uendeshaji wa biashara | 5.34M | -10.53% |
Mapato halisi | -4.93M | 6.29% |
Kiwango cha faida halisi | — | — |
Mapato kwa kila hisa | -0.59 | 9.23% |
EBITDA | -5.29M | 10.53% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
(USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 35.86M | -34.08% |
Jumla ya mali | 38.20M | -34.24% |
Jumla ya dhima | 4.76M | -11.55% |
Jumla ya hisa | 33.44M | — |
hisa zilizosalia | 8.39M | — |
Uwiano wa bei na thamani | 0.70 | — |
Faida inayotokana na mali | -33.03% | — |
Faida inayotokana mtaji | -37.23% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
(USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato halisi | -4.93M | 6.29% |
Pesa kutokana na shughuli | -2.52M | 29.72% |
Pesa kutokana na uwekezaji | -6.30M | -151.46% |
Pesa kutokana na ufadhili | 0.00 | 100.00% |
Mabadiliko halisi ya pesa taslimu | -8.78M | -200.53% |
Mtiririko huru wa pesa | -1.00M | 39.01% |
Kuhusu
Lisata Therapeutics is an American clinical stage pharmaceutical company active in the field of oncology, specifically aimed at developing and commercializing new cancer therapies. It was formed through the acquisition of Cend Therapeutics by Caladrius Biosciences in September 2022.
In April 2024 the FDA granted their product, certepetide, orphan drug status. Non-clinical data collected by Lisata and others have demonstrated enhanced delivery of various existing and emerging anti-cancer therapies, including chemotherapies, immunotherapies and RNA-based therapeutics when used with certepetide. Wikipedia
Ilianzishwa
1980
Makao Makuu
Tovuti
Wafanyakazi
25